A new market study, titled “Global Nuclear Medicine/Radiopharmaceuticals Market Research Report 2018”, has been featured on WiseGuyReports.
This report studies the global Nuclear Medicine/Radiopharmaceuticals market status and forecast, categorizes the global Nuclear Medicine/Radiopharmaceuticals market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.
The major manufacturers covered in this report
China Isotope & Radiation
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
Request Sample Report at https://www.wiseguyreports.com/sample-request/3236392-global-nuclear-medicine-radiopharmaceuticals-market-research-report-2018
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
The study objectives of this report are:
To analyze and study the global Nuclear Medicine/Radiopharmaceuticals sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Nuclear Medicine/Radiopharmaceuticals manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Nuclear Medicine/Radiopharmaceuticals are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Nuclear Medicine/Radiopharmaceuticals Manufacturers
Nuclear Medicine/Radiopharmaceuticals Distributors/Traders/Wholesalers
Nuclear Medicine/Radiopharmaceuticals Subcomponent Manufacturers
Table of Contents
1 Nuclear Medicine/Radiopharmaceuticals Market Overview
2 Global Nuclear Medicine/Radiopharmaceuticals Market Competition by Manufacturers
3 Global Nuclear Medicine/Radiopharmaceuticals Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Nuclear Medicine/Radiopharmaceuticals Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Nuclear Medicine/Radiopharmaceuticals Production, Revenue (Value), Price Trend by Type
6 Global Nuclear Medicine/Radiopharmaceuticals Market Analysis by Application
7 Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Profiles/Analysis
8 Nuclear Medicine/Radiopharmaceuticals Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2025)
13 Research Findings and Conclusion
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)